Influx Healthtech Limited — Important, 16-10-2025: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Influx Healthtech secured FSSAI license for its new facility, boosting tablet manufacturing. This adds 10,000-15,000 bottles/day capacity, totaling 30,000-35,000 bottles/day. Investment of ₹0.60 Cr, funded internally, aims to meet demand and drive revenue growth.